US Patent 12103976 Fc binding fragments comprising a CD137 antigen-binding site
Patent 12103976 was granted and assigned to invoX Pharma on October, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+27 properties)
Article (+294 characters)
US Patent 12103976 Fc binding fragments comprising a CD137 antigen-binding site
Article
Patent abstract
The invention relates to specific binding members that bind CD137. The specific binding members comprise a CD137 antigen-binding site located in a constant domain of the specific binding member and find application in the treatment of cancer and infectious diseases, for example.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Jose Munoz-Olaya0
Matthew Lakins0
Mihriban Tuna0
Sarka Pechouckova0
Date of Patent
October 1, 2024
0Patent Application Number
172597540
Date Filed
July 12, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12103976 Fc binding fragments comprising a CD137 antigen-binding site
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.